Shares of fintech Block fell 14.5% in premarket trading on Friday, as investors balked at profit growth lagging volume increase at its payments unit, Square. ...

KKR reported a rise in third-quarter profit that beat Wall Street's expectations on Friday, boosted by strong fundraising, particularly in its insurance unit and credit. ...

Core Insights - Expedia's shares increased by 15.8% in premarket trading following a positive revenue and margin growth forecast for 2025, driven by strong bookings from business clients [1] Group 1 - The company anticipates higher revenue for 2025, indicating a positive outlook for its financial performance [1] - The expected growth in margins suggests improved profitability alongside revenue increases [1] - Strong bookings from business clients are a key factor contributing to the optimistic forecast [1]

Fragrances have become a staple for Gen Z shoppers, the fastest-growing buyer category globally, and beauty heavyweights are here for the trend. ...

The U.S. Labor Department on Friday will not publish its closely watched employment report for an unprecedented second straight month as the government remains shut, and fears are mounting October's report might not be released when full operations resume. ...

Core Insights - Aumovio, a German automotive supplier, has received an exemption from China to resume exports of its chips, indicating a resolution to supply chain pressures related to the Nexperia dispute [1] Group 1 - Aumovio is facing supply chain pressures due to the ongoing issues with Nexperia [1] - The company's chief executive announced the exemption from China, allowing for the resumption of chip exports [1]

Core Viewpoint - Shares in Novo Nordisk declined following a deal between Eli Lilly and U.S. President Donald Trump to reduce prices of GLP-1 weight-loss medications [1] Company Summary - Novo Nordisk's stock experienced a drop at market opening on Friday due to competitive pricing pressures from a new agreement involving Eli Lilly [1] - The agreement aims to lower the costs of GLP-1 weight-loss drugs, which could impact Novo Nordisk's market position and sales [1] Industry Summary - The deal between Eli Lilly and the U.S. government signifies a shift in the pharmaceutical industry towards more aggressive pricing strategies for weight-loss medications [1] - This development may lead to increased competition in the GLP-1 drug market, affecting pricing and accessibility for consumers [1]

Core Points - Honda is recalling 406,290 vehicles in the U.S. due to a potential issue with aluminium alloy wheels sold as accessories, which may detach from the vehicle because of a manufacturing error [1] Company Summary - The recall affects a significant number of vehicles, indicating a potential risk to consumer safety and could impact Honda's reputation [1] - The U.S. National Highway Traffic Safety Administration has reported the recall, highlighting regulatory oversight in the automotive industry [1]

Core Insights - Tesla's CEO Elon Musk anticipates that the company's Full Self-Driving software will receive full approval in China by early next year [1] Company Summary - The Full Self-Driving software is a driver assistance system developed by Tesla [1]

Core Points - Greencore has received in principle acceptance from the UK competition regulator for its proposed remedy regarding the acquisition of Bakkavor, a convenience food rival [1] - The completion of the deal is now targeted for early 2026 [1]